According to IQVIA's latest financial reports the company's current EPS (TTM) is $5.66. In 2022 the company made an earnings per share (EPS) of $5.81 an increase over its 2021 EPS that were of $5.05.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $5.66 | -2.58% |
2022 | $5.81 | 15.05% |
2021 | $5.05 | |
2019 | $0.98 | -22.83% |
2018 | $1.27 | -79.52% |
2017 | $6.20 | 262.57% |
2016 | $1.71 | -45.71% |
2015 | $3.15 | 13.31% |
2014 | $2.78 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Nymox Pharmaceutical NYMX | -$0.11 | -101.94% | Bahamas |
![]() NRC Health
NRC | $1.22 | -78.45% | ๐บ๐ธ USA |